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OBJECTIVES We hypothesized that exercise-related periodic breathing (EPB) would be associated with
poor prognosis in advanced chronic heart failure (CHF).
BACKGROUND Patients with CHF might present instability of the ventilatory control system characterized
by cyclic waxing and waning of tidal volume (periodic breathing [PB]). This condition is
associated with several deleterious circulatory and neuro-endocrine responses; in fact, PB in
awake and asleep patients has been identified as an independent risk factor for cardiac death.
During exercise, however, the prognostic value of PB is still unknown in CHF patients
awaiting heart transplantation.
METHODS Eighty-four patients with established CHF (65 male, 19 female) were submitted to clinical
evaluation, echocardiogram, ventricular scintigraphy, determination of resting serum norepi-
nephrine levels, and an incremental cardiopulmonary exercise test on cycle ergometer.
Patients were followed for up to 49.7 months (median  15.3), and 26 patients (30.9%) died
during this period.
RESULTS Twenty-five of 84 patients presented EPB (29.7%). The following variables were related to
mortality according to Kaplan-Meier and univariate Cox regression analysis: EPB (p 
0.004), New York Heart Association class (p 0.04), serum norepinephrine (p 0.06), peak
oxygen uptake (mlmin1kg1 and % predicted; p  0.085 and p  0.10, respectively), slope
of the ratio of change in minute ventilation to change in carbon dioxide output during exercise
(p  0.10), and scintigraphic left ventricular ejection fraction (p  0.10). Cox multivariate
analysis identified EPB as the only independent variable for cardiac death prediction (p 
0.007). Therefore, EPB alone was associated with a 2.97-fold increase in risk of death in this
population (95% confidence interval  1.34 to 6.54).
CONCLUSIONS Exercise-related periodic breathing independently predicts cardiac mortality in CHF patients
considered for heart transplantation. (J Am Coll Cardiol 2003;41:2175–81) © 2003 by the
American College of Cardiology Foundation
Chronic heart failure (CHF), a leading cause of morbidity
worldwide, is closely related to increased prevalence of lethal
cardiac events (1). Recent developments in surgical treat-
ment of CHF imply that patients at high risk of such
catastrophic outcomes should be actively sought for. Ac-
cordingly, several predictors of poor clinical prognosis in
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CHF have been recognized: low left ventricular ejection
fraction (LVEF) (2), enlarged left atrium with mitral
regurgitation (3), increased left ventricular cavity width (4),
and increased sympathetic nerve activity (5). Unfortunately,
however, this extensive group of predicting factors still lacks
accuracy for outcome prediction, and the prevalence of fatal
cardiac events in CHF populations is still excessive (1).
Exercise intolerance is a hallmark of advanced, symptom-
atic CHF (1). Low maximum oxygen consumption (peak
V˙O2), for instance, has been widely used for risk stratifica-
tion in this patient population (6–8). Peak V˙O2, however,
has a limited prognostic power even when circulatory-
limited patients are evaluated (9,10). More recently, an
increased ventilatory response to the metabolic demand, as
inferred by a steeper slope of the ratio of change in minute
ventilation to change in carbon dioxide output (V˙E/
V˙CO2) during progressive exercise, has been proposed to
improve outcome prediction (11,12). In fact, hyperventila-
tion and low arterial CO2 at rest and during sleep (13) are
associated with cyclic waxing and waning of tidal volume
(VT) in CHF patients, a condition known as periodic
breathing (PB) (13,14). Interestingly, a severe form of PB
characterized by ventilatory oscillations interposed with
central apneas or hypopneas (Cheyne-Stokes respiration
[CSR]) has been identified as an independent predictor of
mortality in awake (15) and asleep patients with CHF
(16,17). In this context, Corra` et al. (18) have recently
shown that exercise-related PB (EPB) also holds prognostic
implications in a clinically heterogeneous group of cardiac
patients who have been submitted to cardiopulmonary
exercise testing. Considering that the prognostic value of a
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given variable is highly dependent on specific population
characteristics, it is not known whether these findings could
be extrapolated for patients at higher risk of cardiac death
(i.e., those with end-stage disease considered for heart
transplantation).
We therefore sought to investigate the clinical value of
EPB in predicting cardiac death in a group of patients with
advanced CHF who were under evaluation for heart trans-
plantation. To gain further insight into the pathophysio-
logic mechanisms underlying this condition, we also con-
trasted the functional characteristics of the ventilatory
control system in patients with and in those without EPB.
METHODS
Patient population. The study group was comprised of 84
consecutive patients (mean age [ SD] 45 10 years, 65
males and 19 females) with an established diagnosis of CHF
who had clinical and/or functional indication for cardiac
transplantation. Forty-four patients were classified as New
York Heart Association (NYHA), class III and the remain-
ing patients as class II. Although 12 patients were initially
classified as class IV, no patients remained in this class after
optimal clinical management. Inclusion criteria were as
follows: more than six-month history of CHF (actual values
being 73.9  48.0 months), unchanged medication within
the last month, and no acute coronary event within six
months preceding the study. Patients with body mass index
above 30 kgm2 and other clinical conditions such as
hepatic, hematologic, renal, infectious, or pulmonary dis-
eases (including smokers) were also excluded because they
are not considered suitable candidates in our transplantation
program (19).
Etiology of heart failure was dilated cardiomyopathy in
48 cases (56.5%), ischemic in 15 (17.7%), Chagas’ disease in
11 (12.9%), alcoholic in 4 (4.7%), rheumatic in 5 (5.9%),
and post-partum in 2 patients (2.4%). Data were pooled for
analysis only after certification that there was no significant
effect of specific disease prevalence on EPB frequency.
Current medication included digoxin (92%), angiotensin-
converting enzyme inhibitors (88%), furosemide (88%),
hydrochlorotyazide (30%), potassium chloride (19%), beta-
blockers (6%), amiodarone (11%), spironolactone (7%), and
nitrates (7%). Seventy-three patients (86.9%) presented in
sinus rhythm, and 11 (13.1%) were in chronic atrial fibril-
lation. Informed consent as approved by the Institutional
Medical Ethics Committee was obtained from all subjects.
Resting evaluation. Doppler echocardiogram with color
flow imaging was performed in A and B modes using a
multifrequency electronic transducer (Apogee 800Plus, Ad-
vanced Technology Laboratories, Bothell, Washington).
Gated blood pool scintigraphy in a semi-recumbent position
was carried out with a scintigraphic chamber LEM-Plus
(Siemens Gammasonics Inc., Des Paines, Illinois) and a
low-energy collimator using intravenous pyrophosphate fol-
lowed by injection of erythrocytes labeled with technetium-
99m (30 mCi). Electrocardiogram-triggered diastolic and
systolic images (64  64 pixels) were obtained in left
anterior oblique view for the LVEF calculation. Serum
epinephrine levels were measured after 1 h of rest from
antecubital venous blood (n  64) using a high-
performance liquid chromatography-pulsed electrochemical
detector (model 464, Waters, Milford, Massachusetts).
Exercise studies. Cardiopulmonary exercise tests were per-
formed on an electromagnetic-braked cycle ergometer fol-
lowing a ramp-incremental protocol to the limit of toler-
ance. Pulmonary gas exchange and ventilatory variables were
obtained from calibrated signals derived from rapidly re-
sponding gas analyzers and a pneumotachograph (CPX
System, Medical Graphics Corp., St. Paul, Minnesota).
The following variables were recorded breath-by-breath and
expressed as the moving average of eight breaths: pulmonary
oxygen uptake (V˙O2, lmin
1), pulmonary carbon dioxide
output (V˙CO2, lmin
1), minute ventilation (V˙E, lmin1),
and end-tidal partial pressure for CO2 (PETCO2, mm Hg).
Peak V˙O2 values were compared with those predicted by
Hansen et al. (20), considering gender, age, and height. The
slope of V˙E/V˙CO2 was determined by regression anal-
ysis throughout the linear phase of this submaximal rela-
tionship (11,12).
Assessment of PB. Periodic breathing during exercise was
established [EPB()] according to the following criteria
present on ventilation measurements: 1) three or more
regular oscillations (i.e., clearly discernible from inherent
data noise); 2) regularity was defined if the standard
deviation of three consecutive cycle lengths (time between 2
consecutive nadirs) was within 20% of the average; 3)
minimal average amplitude of ventilatory (V˙E) oscillation of
5 l (peak value minus the average of two in-between
consecutive nadirs) (Fig. 1).
Follow-up events on prognosis. The study end point was
cardiac death. The four heart transplantation cases were
considered as censored data at the day of surgery. The
patients were followed for up to 49.7 months (median 11.3
months; interquartile range 6.0 to 21.8 months) on regular
visits to the outpatient clinic at least twice a year. Informa-
tion of the absent patients was obtained by telephone call;
Abbreviations and Acronyms
CHF  chronic heart failure
CSR  Cheyne-Stokes respiration
EPB  exercise-related periodic breathing
LVEF  left ventricular ejection fraction
NYHA  New York Heart Association
PaCO2  arterial carbon dioxide pressure
PB  periodic breathing
PETCO2  end-tidal partial pressure for carbon dioxide
V˙CO2  carbon dioxide output
Vds  dead space volume
V˙E  minute ventilation
V˙O2  oxygen uptake
VT  tidal volume
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all deaths were confirmed through evaluation of medical
recordings.
Statistical analysis. Mean and standard deviations (SD)
were obtained for values in subjects grouped according to
clinical outcome and presence or not of EPB. Kaplan-Meier
log-rank and univariate Cox regression analysis were used to
correlate categorical or continuous variables to time-to-
event, respectively. Meaningful correlated variables (p 
0.10) were then included in a multivariate stepwise forward
conditional Cox regression analysis. Significance of the
regression coefficients was assessed by considering the as-
ymptotic normality property of maximum likelihood esti-
mates (Wald statistic). Serum norepinephrine data were
excluded from the multivariate analysis because only 62
patients had serum determination. Kaplan-Meier cumula-
tive survival curves were constructed and compared using
the Mantel-Haenszel log-rank test. Student t test and
chi-squared tests were applied as appropriate for between-
groups comparison. The p value of a type I error was
established at 0.05 for all hypothesis tests.
RESULTS
Population characteristics. Maximum exercise capacity
was consistent with that expected in patients with ad-
vanced CHF; actual peak V˙O2 values were 16  5.2
mlmin1kg1min1 or 51  15.1% of predicted. Resting
echocardiographic data showed severe heart damage with
reduced LVEF (35  6.6%) and increased left ventricle
end-diastolic and end-systolic and left atrium diameters (74
 11.4 mm, 63  12.0 mm, and 47  7.5 mm, respective-
ly). Similarly, scintigraphic evaluation showed a severely
reduced LVEF (22 7.4%), and resting serum norepineph-
rine levels were typically elevated (582  278.6 gdl1).
Clinical and functional correlates of EPB. Twenty-five
of 84 patients (29.7%) presented EPB; cardiac deaths were
identified in 26 subjects (30.9%). The one-year and two-
year cumulative survival rates were 82% and 57%, respec-
tively. We first investigated possible clinical and functional
differences between EPB() and EPB() patients. As
shown in Table 1, EPB() patients presented lower peak
V˙O2, higher V˙E/V˙CO2 slope, and lower pre-exercise
Figure 1. A representative example of a patient presenting with exercise-related periodic breathing (EPB). Diagnosis of EPB was based on presence of
frequent (at least 3 cycles), regular (standard deviation of three consecutive cycle lengths [] within 20% of their average), and ample (minimum amplitude
[h] of 5 lmin1) minute ventilation (V˙E) oscillations.
Table 1. Characteristics of Patients According to Presence
of EPB
Variables
EPB()
(n  59)
EPB()
(n  25)
Demographic
Age (yrs) 44.1  9.5 47.2  11.0
Gender (M/F) 45/14 20/5
Exercise
Peak V˙O2 (% pred) 54.1  15.5 42.3  10.1*
Peak V˙O2 (mlmin
1kg1) 16.5  5.4 13.0  3.3*
Resting PETCO2 (mm Hg) 37.8  4.5 34.2  3.6*
V˙E/V˙CO2 slope 39.5  11.7 48.7  6.8*
PB cycle length (s) — 78.8  22.5
PB amplitude (l) — 9.8  4.0
PB amplitude  length — 808  467
Norepinephrine (ng/dl) 552  276 655  276
Echocardiogram
LV diastolic diameter (mm) 73.0  12.8 75.6  6.9
LV systolic diameter (mm) 63.1  12.2 64.1  11.6
LVEF (%) 35.3  6.4 33.5  6.8
Left atrium diameter (mm) 47.8  6.8 46.5  8.7
Scintigraphy
LVEF (%) 23.1  7.6 20.6  6.6
Values are mean  SD. *p  0.05: EPB() versus EPB() patients.
EPB  exercise-related periodic breathing; LV  left ventricular; LVEF  left
ventricular ejection fraction; PB  periodic breathing; PETCO2  end-tidal partial
pressure for carbon dioxide; V˙CO2  carbon dioxide output; V˙E  minute
ventilation; V˙O2  oxygen uptake.
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PETCO2 values than EPB() patients (p  0.01). On the
other hand, there were no significant between-group differ-
ences in relation to the other variables, including LVEF.
We also found similar time delays from initial symptoms of
CHF to exercise testing in both patient groups (22.9  7.5
vs. 20.6  5.8 months; p  0.21). Furthermore, we found
a marginally significant association between higher func-
tional classification and EPB: 17 of 25 of EPB() patients
(68%) were classified as NYHA class III, but only 27 of 59
of EPB() patients (45.7%) were in this class (p  0.06).
EPB and cardiac death. Time-corrected univariate regres-
sion analysis depicted the following variables as predictors of
mortality: EPB() (log-rank  7.98; p  0.004); NYHA
functional classification (log-rank  4.00, p  0.04); serum
norepinephrine (Wald 3.50; p  0.06); V˙ O2
[mlmin1kg1] (log-rank  2.95; p  0.085) and [%
predicted] (Wald  2.68; p  0.10); V˙E/V˙CO2 slope
(Wald 2.65; p 0.10); and scintigraphic LVEF (Wald
2.59; p  0.10). Conversely, age, gender, resting PETCO2
values, and echocardiographic LVEF were not significantly
associated with mortality (p  0.10).
The multivariate analysis demonstrated that EPB was the
only independent predictor of cardiac death (i.e., no other
variable could be added to the final model) (p  0.007).
Therefore, the risk of death for EPB() patients was 2.97
times greater than for EPB() patients (95% confidence
interval  1.34 to 6.54). Figure 2 depicts the Kaplan-Meier
survival curves for both groups: one- and two-year cumula-
tive survival rates were 89% to 63% and 67% to 45% for
EPB() and EPB() patients, respectively. Similar results
were obtained when we considered transplantation (n  4)
as the final event.
DISCUSSION
We have prospectively investigated the role of EPB in
predicting cardiac death in a group of patients with ad-
vanced CHF under evaluation for heart transplantation.
The novel findings of our study were: 1) EPB was frequent
(about 30%) and easily recognized by using clinically useful
criteria; 2) it almost tripled the average risk of cardiac death
(Fig. 2), independent of traditional demographic, clinical,
and resting functional variables; and 3) EPB was associated
with steeper V˙E/V˙CO2 slope during exercise and low
PETCO2 at rest (i.e., excessive ventilatory response). This
seems to constitute the first study to demonstrate the
practical value of this disorder in predicting mortality in
patients with end-stage CHF in evaluation for heart trans-
plantation. Our results, therefore, suggest that evidence of
EPB during routine cardiopulmonary exercise testing
should be sought and clinically valued for risk stratification
in this specific patient population.
Cardiopulmonary exercise testing has an established role
for prognostic evaluation of patients with CHF. It is well
known, for example, that reduction of peak V˙O2 relates to
poor prognosis in this population (6,7)—as we could con-
firm in the present study. However, interpretation of peak V˙O2
values is fraught with complexities in patient populations. The
Figure 2. Kaplan-Meier survival curve for patients presenting with or not presenting with periodic breathing during dynamic exercise [EPB() and
EPB(), respectively]. Note that EPB() patients presented a significantly higher time-adjusted mortality rate (p  0.01), independent of clinical and
functional data.
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multifactorial etiology of exercise limitation in this syndrome
implies that limited cardiac output might not be the sole culprit
for an eventually reduced peak V˙O2. In fact, other cardio-
respiratory and metabolic disturbances are common in CHF:
recent data demonstrate that evaluation of submaximal exercise
is useful to unravel these disorders (11,12,21). In this context,
our findings are particularly relevant because identification of
EPB does not depend on patients’ maximal effort or attain-
ment of a truly circulatory-limited peak V˙O2.
Prognosis of EPB. Respiratory instability has long been
associated with poor prognosis in CHF (14). In fact,
evidence that this disorder is frequent among CHF patients
(22,23) and is an independent and powerful predictor of
mortality, whether during the day (15) or night (16,17), is
accruing. Several studies have now demonstrated that CSR
during sleep is associated with recurrent hypoxia, increased
number of awakenings, enhanced sympathetic activity,
and poor prognosis (13,14,16,17,22,23). In these pa-
tients, episodes of PB induce fluctuations in heart rate,
blood pressure, and gases that are associated with activa-
tion of neuro-endocrine responses and a state of chronic
sympathetic over-activity—well-known triggers of lethal
ventricular arrhythmias (14). Indeed, Javaheri and Cor-
bett (24) found a high prevalence of ventricular tachy-
cardia in CHF patients with hypocapnia and central
apnea, suggesting a possible mechanism for the cardiac
deaths related to CSR. The same pathophysiologic mech-
anisms could be associated with mortality in EPB: several
daily episodes of exertion-related ventilatory instabilities
would elicit a chronic status of systemic neuro-endocrine
and circulatory over-activation with harmful effects on
the failing heart.
More recently, Corra` et al. (18) found a significant
association between EPB and cardiac death in a study
involving a population of CHF patients in different stages of
the disease who were referred for CPX evaluation. Our
longitudinal study further extends their findings by showing
that in a selected group of very limited patients considered
for cardiac transplantation, EPB is more frequent (30% vs.
12%) and an even more powerful predictor of mortality than
in their series of patients with a broader clinical spectrum. In
fact, we were unable to add any other variable in the
predictive model for cardiac death when EPB was consid-
ered. This finding contrasts with those of Corra` et al., who
found that peak V˙O2 and LVEF were also predictors of
major cardiac events. Interestingly, our data suggest that
identification of EPB is not related to duration of the
disease: we were unable to find significant differences in
time delay from initial symptoms of CHF to exercise testing
in EPB() versus EPB() patients.
Our data, therefore, seem to be particularly relevant in
clinical terms, because this sample epitomizes a population
under increased risk of sudden cardiac death (i.e., a group
for which ominous predictors should be especially sought).
In addition, the present study shed light on the pathophys-
iologic determinants of EPB: an excessive ventilatory re-
sponse to the metabolic demand is likely to play a role in the
genesis of this disorder (Table 1).
Relationship between CHF and periodic breathing.
Periodic breathing is characterized by a periodic and cyclic
waxing and waning of VT. Cheyne-Stokes respiration, for
instance, is a severe form of PB in which apneas or
hypopneas are alternated with periods of ventilatory oscil-
lation. The mechanisms involved in the etiology of PB are
multifactorial and not completely understood. It seems
likely, however, that it represents a clinical manifestation of
instability of the respiratory control center (14).
It has long been recognized that the central respiratory
controllers are strongly influenced by chemoreceptor activ-
ity, especially by the level at which the mean arterial pressure
for CO2 (PaCO2) is regulated (CO2 set-point) (14). In fact,
low PaCO2 plays a major role in the pathogenesis of CSR
in CHF (13,14). It has been demonstrated, for instance,
that these patients are typically hypocapnic at rest and asleep
(13). Furthermore, inhalation of low concentrations of CO2
during sleep is able to abolish CSR in conjunction with a
small, but significant, increase in PaCO2 (25). In CHF
patients, hypocapnia might be caused by over-stimulation of
the ventilatory control center due to chronic pulmonary
congestion (26,27) and increased central (28) and peripheral
(29) chemosensitivity. Circulatory delay could also increase
the lag time between pulmonary gas-exchanging capillaries
and carotid chemoreceptors with consequent increase in
gain of the feedback loop. These effects are prone to further
contribute to the underlying instability of the respiratory
center (14).
Periodic breathing during exercise. The physiologic ad-
justments during dynamic exercise can produce additional
sources of excessive ventilatory response and, therefore,
promote further instabilities (30,31). Exercise stimulation of
the over-active ergoreceptors during exercise may exces-
sively stimulate the respiratory centers. Group III and IV
afferents can respond to accumulated by-products of muscle
metabolism and changes in local vascular peripheral con-
ductance (32). Exercise-induced pulmonary capillary con-
gestion, as we have previously demonstrated (33), may also
activate lung stretch receptors (14,27). In addition, an
excessive ventilatory response could be associated with
increased “wasted” ventilation due to enlarged physiologic
dead space volume (Vds) and/or reduced VT (i.e., higher
Vds/VT ratio during exercise) (34).
The linear relationship between V˙E and V˙CO2 that
characteristically develops during most of the incremental
phase of dynamic exercise (V˙E/V˙CO2) has been used as
an index of the ventilatory efficiency based on the following
reasoning (34):
V˙E 	BTPS
  863 V˙CO2 	STPD
/PaCO2 	1  Vds/VT

From this construct, it is clear that an increased V˙E/
V˙CO2 slope might be related to reduced CO2 set-point
(i.e., hyperventilation) and/or an enlarged dead space frac-
tion of the breath (i.e., a tachypneic breathing pattern). In
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our study, EPB() patients presented not only higher
V˙E/V˙CO2 slope but also lower resting PETCO2 (Table
1). Unfortunately, however, excessive Vds is associated with
a positive arterial-end tidal CO2 pressure gradient (i.e.,
PETCO2 can underestimate PaCO2 by an unknown
amount when the “wasted” ventilation is increased). Con-
sidering that we did not directly measure PaCO2 or other
indexes of pulmonary gas exchange efficiency, we cannot
rule out that Vds/VT was disproportionately increased in
the more severe patients (i.e., those who presented higher
prevalence of EPB) (Table 1). Even taking into consider-
ation these limitations, we consider that our data are
consistent with the hypothesis that excessive ventilation
during exercise might further contribute to respiratory
instability and, therefore, development of EPB in end-stage
CHF.
Study limitations. Although the criteria we used to define
EPB could have underestimated its true prevalence, we
reasoned that a more sophisticated analysis (such as power
spectral analysis) (35) would be prone to hamper the
practicality of this approach in clinical settings. Indeed,
similar criteria for EPB identification have been recently
demonstrated to be reliable and reproducible (18); never-
theless, we recognize that the present study lacks a formal
test–retest analysis for EPB reproducibility.
We found only a weak association between LVEF and
mortality. This finding could be related to the small vari-
ability of this measurement in a relatively homogeneous
population with advanced disease. However, it is worth
noting that other well-known predictors of mortality, such
as functional status, peak V˙O2, and norepinephrine levels,
were significantly related to death (see Results). It is
conceivable that the introduction of newer, more effective
drugs after the initial cardiopulmonary exercise testing may
have favorably changed the prognosis and, therefore, may
lessen the importance of PB in predicting mortality. In
addition, some specific characteristics of our sample should
be taken into consideration for analysis of the study results.
First, no NYHA class IV patient was evaluated; as discussed
in Methods, however, 12 patients had been classified as class
IV before optimal clinical management. Second, Chagas’
disease was the specific etiology of CHF in 12.9% of the
patients; as mentioned, we were unable to identify an
independent effect of CHF etiology on EPB frequency.
Finally, these patients were typically younger than those
evaluated by other authors. Although the effect of age on
EPB is to date unknown, we cannot rule out the possibility
that our main outcome was influenced by this demographic
characteristic.
Clinical implications. Our study provides original evi-
dence that in CHF patients awaiting heart transplantation
EPB is common, can be easily recognized, and constitutes a
powerful predictor of mortality. Therefore, EPB on routine
cardiopulmonary exercise testing should be looked for,
reported, and clinically valued for risk stratification in CHF
patients considered for heart transplantation.
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